Clinical Trials
48 trialsDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
ADJUPANET
Gustave Roussy, Cancer Campus, Grand Paris
PRO-COMAND
University of Pisa
AI in Endoscopic Transsphenoidal Surgery
University College, London
ALPINE 2
Technische Universität Dresden
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Moonlight Bio, Inc
Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Mayo Clinic
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
REPOTHYROID-II
Radboud University Medical Center
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
University of Michigan Rogel Cancer Center
STRAP
National Cancer Centre, Singapore
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
ADERADHTA2
University Hospital, Toulouse
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Mayo Clinic
Empirical Radioactive Iodine Therapy in DTC
Assiut University
DETERMINE
Cancer Research UK
FOMUTI
University Hospital, Rouen
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
REWENEC 01
Hospices Civils de Lyon
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
West China Hospital
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
Sun Yat-sen University
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Beijing GoBroad Hospital
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
MAeSTro-TSH
National Cancer Center, Korea
MAeSTro-SDM
National Cancer Center, Korea
A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer
Beijing GoBroad Hospital
Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
Sun Yat-sen University
Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
Hansoh BioMedical R&D Company
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Guangdong Provincial People's Hospital
TAURUS
National Taiwan University Hospital
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
West China Hospital
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Beijing Chest Hospital
A Community-Based Intervention to Reduce Alcohol Use in Vietnamese Men
Chulalongkorn University
Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
HETERERO
Charite University, Berlin, Germany
A Study of Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy
Shanghai Changzheng Hospital
Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine Tumors
Peking University
Endoscopic Resection for Small Rectal Neuroendocrine Tumors
Nanfang Hospital, Southern Medical University